Viewing Study NCT00952692


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2025-12-26 @ 7:16 PM
Study NCT ID: NCT00952692
Status: COMPLETED
Last Update Posted: 2021-12-20
First Post: 2009-08-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer
Sponsor: Michael Morse, MD
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-07
Start Date Type: None
Primary Completion Date: 2011-07
Primary Completion Date Type: ACTUAL
Completion Date: 2012-04
Completion Date Type: ACTUAL
First Submit Date: 2009-08-04
First Submit QC Date: None
Study First Post Date: 2009-08-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-11-18
Results First Submit QC Date: None
Results First Post Date: 2021-12-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2012-11-20
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2021-11-18
Last Update Post Date: 2021-12-20
Last Update Post Date Type: ACTUAL